Elsevier

Genomics

Volume 33, Issue 1, 1 April 1996, Pages 46-52
Genomics

Regular Article
Genetic and Physical Mapping at the Limb-Girdle Muscular Dystrophy Locus (LGMD2B) on Chromosome 2p

https://doi.org/10.1006/geno.1996.0157Get rights and content

Abstract

The limb-girdle muscular dystrophies (LGMD) are a genetically heterogeneous group of disorders, different forms of which have been mapped to at least six distinct genetic loci. We have mapped an autosomal recessive form of LGMD (LGMD2B) to chromosome 2p13. Two other conditions have been shown to map to this region or to the homologous region in mouse: a gene for a form of autosomal recessive distal muscular dystrophy, Miyoshi myopathy, shows linkage to the same markers on chromosome 2p as LGMD2B, and an autosomal recessive mouse mutationmnd2,in which there is rapidly progressive paralysis and muscle atrophy, has been mapped to mouse chromosome 6 to a region showing conserved synteny with human chromosome 2p12–p13. We have assembled a 6-cM YAC contig spanning the LGMD2B locus and have mapped seven genes and 13 anonymous polymorphic microsatellites to it. Using haplotype analysis in the linked families, we have narrowed our region of interest to a 0-cM interval between D2S2113 and D2S2112/D2S145, which does not overlap with the critical region formnd2in mouse. Use of these most closely linked markers will help to determine the relationship between LGMD2B and Miyoshi myopathy. YACs selected from our contig will be the starting point for the cloning of the LGMD2B gene and thereby establish the biological basis for this form of muscular dystrophy and its relationship with the other limb-girdle muscular dystrophies.

References (0)

Cited by (62)

  • Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle

    2013, International Journal of Biochemistry and Cell Biology
    Citation Excerpt :

    Dysferlinopathies, also called dysferlin myopathies, are a heterogenous group of progressive muscular dystrophies characterized by mutations in the DYSF gene (Bashir et al., 1998; Liu et al., 1998). These mutations produce reduced or null expression of the dysferlin protein and can cause a variety of phenotypes (Illa et al., 2007, 2001; Nguyen et al., 2007; Paradas et al., 2009; Passos-Bueno et al., 1995), such as limb girdle muscular dystrophy type 2B (LGMD2B) (Bashir et al., 1996) or Miyoshi myopathy (MM) (Miyoshi et al., 1986). Dysferlin myopathies present with muscle weakness and high levels of creatinin kinase in serum, and the muscle biopsy shows dystrophic features and inflammatory infiltrates.

View all citing articles on Scopus
View full text